Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

302
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
302
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

662
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
662
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

336
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
336
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

975
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
975
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

563
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
563

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Golden insights from a silver superatom.

National science review·2024
Same author

Mycobacterium smegmatis MfpC is a GEF that regulates mfpA translationally to alter the fluoroquinolone efficacy.

Communications biology·2024
Same author

Enhancing Localized Electron Density over Pd<sub>1.4</sub>Cu Decorated Oxygen Defective TiO<sub>2-x</sub> Nanoarray for Electrocatalytic Nitrite Reduction to Ammonia.

Small (Weinheim an der Bergstrasse, Germany)·2024
Same author

Fluorescent Enhancement of [AgS<sub>4</sub>] Microplates by Mechanical Force Induced Crystallinity Breaking.

The journal of physical chemistry letters·2024
Same author

High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy.

Gut·2024
Same author

Enzyme-activatable charge transfer in gold nanoclusters.

Chemical science·2024

Related Experiment Video

Updated: Nov 29, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K

Differential Isoniazid Response Pattern Between Active and Dormant Mycobacterium tuberculosis.

M A Abo-Kadoum1,2, Yongdong Dai1, Mohammed Asaad1

  • 1Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-Environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Beibei, P.R. China.

Microbial Drug Resistance (Larchmont, N.Y.)
|November 19, 2020
PubMed
Summary

Isoniazid (isonicotinic acid hydrazide, INH) drug stress activates specific gene expression in active tuberculosis bacteria, unlike dormant ones. This differential response highlights pathways for developing new tuberculosis treatments.

Keywords:
DNA synthesisM. tuberculosisdormant stateisoniazidmycolic acid

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.5K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.0K

Related Experiment Videos

Last Updated: Nov 29, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.9K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.5K
A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

8.0K

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pharmacology

Background:

  • Isoniazid (isonicotinic acid hydrazide, INH) is a primary drug for tuberculosis treatment.
  • INH affects key Mycobacterium tuberculosis processes like mycolic acid synthesis and DNA replication.
  • M. tuberculosis exhibits altered gene expression in response to INH-induced stress.

Purpose of the Study:

  • To summarize the gene expression patterns in active M. tuberculosis exposed to INH.
  • To identify pathways significantly affected by INH in M. tuberculosis.
  • To compare INH response patterns between active and dormant M. tuberculosis.

Main Methods:

  • Analysis of gene expression profiles in active M. tuberculosis.
  • Exposure of M. tuberculosis cultures to INH.
  • Comparison of gene expression patterns under different conditions.

Main Results:

  • INH exposure induces significant changes in gene expression in active M. tuberculosis.
  • Upregulated genes are primarily involved in mycolic acid biosynthesis, stress response, and drug efflux.
  • These INH-induced gene expression patterns are not observed in dormant M. tuberculosis.

Conclusions:

  • Active M. tuberculosis mounts a distinct gene expression response to INH.
  • The identified pathways offer potential targets for novel anti-tuberculosis strategies.
  • Understanding differential drug response is crucial for combating tuberculosis effectively.